24.39
Schlusskurs vom Vortag:
$24.86
Offen:
$25
24-Stunden-Volumen:
334.51K
Relative Volume:
0.85
Marktkapitalisierung:
$936.04M
Einnahmen:
$95.07M
Nettoeinkommen (Verlust:
$-60.37M
KGV:
-14.97
EPS:
-1.6291
Netto-Cashflow:
$-50.92M
1W Leistung:
+3.26%
1M Leistung:
+1.71%
6M Leistung:
+33.06%
1J Leistung:
+112.27%
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CBLL
Ceribell Inc
|
24.39 | 909.18M | 95.07M | -60.37M | -50.92M | -1.6291 |
|
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-24 | Eingeleitet | BTIG Research | Buy |
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
Ceribell stock price target reiterated at $30 by BTIG on growth outlook - Investing.com Nigeria
BTIG Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Blumberg Scott Executes 846 Ceribell Options and Disposes Shares on September 15, 2026 - Kalkine Media
CeriBell, Inc. (CBLL) Stock Analysis: Exploring the 12% Potential Upside in the Innovative Medical Device Sector - DirectorsTalk Interviews
Ceribell CFO Scott Blumberg exercises options, sells $21,150 in stock. - Investing.com India
Ceribell president and CEO Chao Xingjuan sells $521,775 in stock By Investing.com - Investing.com Nigeria
Ceribell president and CEO Chao Xingjuan sells $521,775 in stock - Investing.com
Ceribell CFO Scott Blumberg exercises options, sells $21,150 in stock. By Investing.com - Investing.com Canada
Ceribell (CBLL) CEO sells stock under a preset 2025 trading plan - Stock Titan
Ceribell (CBLL) CFO sells 846 shares under 10b5-1 plan - stocktitan.net
CeriBell (CBLL) 10K Form and Latest SEC Filings 2026 - MarketBeat
Ceribell: Q2 Revenue Growth, FDA Clearances And NTAP Reimbursement In Focus - RTTNews
CeriBell, Inc.Common Stock (CBLL) Stock Price, News, Quote & History - FinancialContent
Ceribell CTO Raymond Woo sells $118,900 of company stock By Investing.com - Investing.com South Africa
BTIG reiterates Ceribell stock rating at buy, $30 price target By Investing.com - Investing.com South Africa
BTIG reiterates Ceribell stock rating at buy, $30 price target - Investing.com India
Ceribell senior VP sells $224,451 of company stock - Investing.com India
Ceribell senior VP sells $224,451 of company stock By Investing.com - Investing.com South Africa
Ceribell CTO Raymond Woo sells $118,900 of company stock - Investing.com
Ceribell (CBLL) CTO trades stock under Rule 10b5-1 plan - stocktitan.net
Ceribell (CBLL) finance VP exercises options, sells stock under preset plan - Stock Titan
Ceribell CEO Chao Xingjuan Executes Options and Sells 39,540 Shares at $24.61, Retains 767,191 Shares - Kalkine Media
Electroencephalography Devices Market (2033): Tabletop EEG, - openPR.com
Ceribell CEO Chao Xingjuan sells $973,079 in company stock By Investing.com - Investing.com South Africa
Ceribell CFO Scott Blumberg sells $16,300 in common stock By Investing.com - Investing.com India
Ceribell CFO Scott Blumberg sells $16,300 in common stock - investing.com
Ceribell CEO Chao Xingjuan sells $973,079 in company stock - investing.com
Ceribell (CBLL) CEO sells nearly 40,000 shares under plan - stocktitan.net
CFO at Ceribell (CBLL) sells 652 shares under preset plan - Stock Titan
William Blair Maintains Ceribell(CBLL.US) With Buy Rating - Moomoo
Ceribell, Inc. (CBLL) Gets a Buy from Raymond James - The Globe and Mail
Raymond James raises Ceribell stock price target on new growth drivers - Investing.com Australia
Insiders At CeriBell Sold US$1.0m In Stock, Alluding To Potential Weakness - Moomoo
Ceribell (CBLL) CRO Joseph Manni sells $32,691 in shares By Investing.com - Investing.com India
Ceribell CFO Blumberg sells $36,534 in stock By Investing.com - Investing.com Nigeria
Ceribell CTO Raymond Woo sells $47,535 in company stock By Investing.com - Investing.com Nigeria
Ceribell president and CEO Chao Xingjuan sells $145,753 in stock By Investing.com - Investing.com Nigeria
Ceribell senior VP Foehr sells $44,424 in company stock By Investing.com - Investing.com Australia
Ceribell (CBLL) CFO sells 1,521 shares to cover taxes - Stock Titan
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ceribell Inc-Aktie (CBLL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Blumberg Scott | Chief Financial Officer |
Sep 15 '26 |
Option Exercise |
9.41 |
846 |
7,961 |
147,446 |
| Blumberg Scott | Chief Financial Officer |
Sep 15 '26 |
Sale |
25.00 |
846 |
21,150 |
146,600 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):